相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy
Najat Aourz et al.
ACS CHEMICAL NEUROSCIENCE (2019)
GSK3 beta activity alleviates epileptogenesis and limits GluA1 phosphorylation
Malgorzata Urbanska et al.
EBIOMEDICINE (2019)
Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy
Delia M. Talos et al.
ANNALS OF NEUROLOGY (2018)
Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity
Han Weina et al.
BRAIN RESEARCH (2018)
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
A. Prasanth Saraswati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis
A. J. Becker
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus
Tobias Engel et al.
CELL DEATH & DISEASE (2018)
The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders
Anastasia Levchenko et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)
GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology
Ilona Kondratiuk et al.
MOLECULAR NEUROBIOLOGY (2017)
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Robert S. Fisher et al.
EPILEPSIA (2017)
Dysregulation of PINCH signaling in mesial temporal epilepsy
Charles Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness
Andreas G. Moraitis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Glutamatergic synapses are structurally and biochemically complex because of multiple plasticity processes: long-term potentiation, long-term depression, short-term potentiation and scaling
John Lisman
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
GSK-3β deletion in dentate gyrus excitatory neuron impairs synaptic plasticity and memory
Enjie Liu et al.
SCIENTIFIC REPORTS (2017)
In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
Ambika Krishnankutty et al.
SCIENTIFIC REPORTS (2017)
Up-regulation of SIRT6 in the hippocampus induced rats with depression-like behavior via the block Akt/GSK3β signaling pathway
Qiang Mao et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice
Fumihiro Higuchi et al.
JOURNAL OF NEUROSCIENCE (2016)
GSK3β Hyperactivity during an Early Critical Period Impairs Prefrontal Synaptic Plasticity and Induces Lasting Deficits in Spine Morphology and Working Memory
Bo Xing et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders
R. Gao et al.
CURRENT MOLECULAR MEDICINE (2015)
MOUSE HIPPOCAMPAL PHOSPHORYLATION FOOTPRINT INDUCED BY GENERALIZED SEIZURES: FOCUS ON ERK, mTORC1 AND Akt/GSK-3 PATHWAYS
Giuseppe Gangarossa et al.
NEUROSCIENCE (2015)
Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice
Malay Bhowmik et al.
NEUROTOXICOLOGY (2015)
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
J. J. Credle et al.
CELL DEATH AND DIFFERENTIATION (2015)
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment
Aline Siqueira Ferreira et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Loss of neuronal GSK3 beta reduces dendritic spine stability and attenuates excitatory synaptic transmission via beta-catenin
S. M. Ochs et al.
MOLECULAR PSYCHIATRY (2015)
Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
Aimee V. Franklin et al.
BIOLOGICAL PSYCHIATRY (2014)
Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
Raquel Gomez-Sintes et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation
Meghan Morgan-Smith et al.
ELIFE (2014)
Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice
Ilona Kondratiuk et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Phosphorylation of Threonine-19 of PSD-95 by GSK-3β is Required for PSD-95 Mobilization and Long-Term Depression
Christopher D. Nelson et al.
JOURNAL OF NEUROSCIENCE (2013)
GSK-3β may be involved in hippocampal mossy fiber sprouting in the pentylenetetrazole-kindling model
Wen-Jiao Huang et al.
MOLECULAR MEDICINE REPORTS (2013)
GSK-3β overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo
M. Llorens-Martin et al.
MOLECULAR PSYCHIATRY (2013)
Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction
Ethan M. Goldberg et al.
NATURE REVIEWS NEUROSCIENCE (2013)
GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals
Carol Dobson-Stone et al.
PLOS ONE (2013)
Activity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3β
Yanfang Rui et al.
NATURE COMMUNICATIONS (2013)
Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase
Herve Maurin et al.
MOLECULAR BRAIN (2013)
Lovastatin Modulates Glycogen Synthase Kinase-3β Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus
Chun-Yao Lee et al.
PLOS ONE (2012)
AKT/GSK3 signaling pathway and schizophrenia
Effat S. Emamian
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Laure Freland et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment
Catherine H. Choi et al.
BRAIN RESEARCH (2011)
Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation
Lina Tsaadon Alon et al.
FEBS LETTERS (2011)
Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome
Zhong-Hua Liu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation
Olivia A. Shipton et al.
JOURNAL OF NEUROSCIENCE (2011)
DISC1-dependent switch from progenitor proliferation to migration in the developing cortex
Koko Ishizuka et al.
NATURE (2011)
GSK-3α/β kinases and amyloid production in vivo
Tomasz Jaworski et al.
NATURE (2011)
Dendritic spine pathology in neuropsychiatric disorders
Peter Penzes et al.
NATURE NEUROSCIENCE (2011)
GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort
Kallirhoe Kalinderi et al.
NEUROBIOLOGY OF AGING (2011)
Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
Jonathan Wills et al.
PLOS ONE (2011)
Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrin
Shiva K. Tyagarajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility
Ming Li et al.
SCHIZOPHRENIA RESEARCH (2011)
GSK-3 inhibitors: preclinical and clinical focus on CNS
Hagit Eldar-Finkelman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Alzheimer's disease: Old problem, new views from transgenic and viral models
Tomasz Jaworski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes
Vincent F. Taelman et al.
CELL (2010)
Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease
J. Infante et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3
Jing Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain
Marc P. M. Soutar et al.
JOURNAL OF NEUROCHEMISTRY (2010)
GSK-3β Inhibits Presynaptic Vesicle Exocytosis by Phosphorylating P/Q-Type Calcium Channel and Interrupting SNARE Complex Formation
Ling-Qiang Zhu et al.
JOURNAL OF NEUROSCIENCE (2010)
LKB1-Mediated Spatial Control of GSK3β and Adenomatous Polyposis Coli Contributes to Centrosomal Forward Movement and Neuronal Migration in the Developing Neocortex
Naoyuki Asada et al.
JOURNAL OF NEUROSCIENCE (2010)
A JIP3-Regulated GSK3β/DCX Signaling Pathway Restricts Axon Branching
Parizad M. Bilimoria et al.
JOURNAL OF NEUROSCIENCE (2010)
Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles
Emma L. Clayton et al.
NATURE NEUROSCIENCE (2010)
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Elena Gomez de Barreda et al.
NEUROBIOLOGY OF DISEASE (2010)
Light and Electron Microscopy Study of Glycogen Synthase Kinase-3β in the Mouse Brain
Emma Perez-Costas et al.
PLOS ONE (2010)
Glycogen Synthase Kinase-3β and Tau Genes Interact in Parkinson's and Alzheimer's Diseases
Ines Garcia-Gorostiaga et al.
ANNALS OF NEUROLOGY (2009)
Association of GSK3β Polymorphisms With Brain Structural Changes in Major Depressive Disorder
Becky Inkster et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray et al.
BRAIN (2009)
A clinico-pathological study of subtypes in Parkinson's disease
M. Selikhova et al.
BRAIN (2009)
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
Yingwei Mao et al.
CELL (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Phosphorylation of CLASP2 by GSK-3β regulates its interaction with IQGAP1, EB1 and microtubules
Takashi Watanabe et al.
JOURNAL OF CELL SCIENCE (2009)
β-Catenin Signaling Levels in Progenitors Influence the Laminar Cell Fates of Projection Neurons
Christopher A. Mutch et al.
JOURNAL OF NEUROSCIENCE (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
GSK-3 is a master regulator of neural progenitor homeostasis
Woo-Yang Kim et al.
NATURE NEUROSCIENCE (2009)
GSK3β, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9
I. Dewachter et al.
NEUROBIOLOGY OF DISEASE (2009)
Glycogen synthase kinase-3beta is associated with Parkinson's disease
Masahiro Nagao et al.
NEUROSCIENCE LETTERS (2009)
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Oksana Kaidanovich-Beilin et al.
MOLECULAR BRAIN (2009)
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
Dick Terwel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
A review of Parkinson's disease
C. A. Davie
BRITISH MEDICAL BULLETIN (2008)
Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
D. Muyllaert et al.
GENES BRAIN AND BEHAVIOR (2008)
Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation
Risto Kerkela et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate:: The role of glycogen-synthase-kinase-3β
R. Silva et al.
NEUROSCIENCE (2008)
GSK-3β Is Required for Memory Reconsolidation in Adult Brain
Tetsuya Kimura et al.
PLOS ONE (2008)
Role of adenomatous polyposis coli (APC) and microtubules in directional cell migration and neuronal polarization
Angela I. M. Barth et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Activation of glycogen synthase kinase-3 inhibits LongTerm Potentiation with synapse-associated impairments
Ling-Qiang Zhu et al.
JOURNAL OF NEUROSCIENCE (2007)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons
Paul Chen et al.
MOLECULAR PHARMACOLOGY (2007)
GSK3 alpha and GSK3 beta are necessary for axon formation
Juan Jose Garrido et al.
FEBS LETTERS (2007)
UP inhibits LTD in the hippocampus via regulation of GSK3β
Stephane Peineau et al.
NEURON (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation
Claudie Hooper et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Chronic lithium administration to FTDP-17 tau and GSK-3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert
Tobias Engel et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
Transgenic mouse models for Alzheimer's disease:: the role of GSK-3β in combined amyloid and tau-pathology
D. Muyllaert et al.
REVUE NEUROLOGIQUE (2006)
Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3β) independently of Akt/PKB serine phosphorylation
Annette Gaertner et al.
JOURNAL OF CELL SCIENCE (2006)
Transgenic mice overexpressing glycogen synthase kinase 3β:: A putative model of hyperactivity and mania
Jos Prickaerts et al.
JOURNAL OF NEUROSCIENCE (2006)
Association of AKT1 haplotype with the risk of schizophrenia in Iranian population
Sepideh N. Bajestan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Psychotropic drugs affect Ser9-phosphorylated GSK-3β protein levels in rodent frontal cortex
Nitsan Kozlovsky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Non-convulsive status epilepticus during lithium treatment at therapeutic doses
M Bellesi et al.
NEUROLOGICAL SCIENCES (2006)
Genetics of affective (mood) disorders
Nick Craddock et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
JBJ Kwok et al.
ANNALS OF NEUROLOGY (2005)
The effects of antipsychotics on β-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats
H Alimohamad et al.
JOURNAL OF NEUROCHEMISTRY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3β and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells
YI Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons
N Trivedi et al.
JOURNAL OF CELL SCIENCE (2005)
Both the establishment and the maintenance of neuronal polarity require active mechanisms:: Critical roles of GSK-3β and its upstream regulators
H Jiang et al.
CELL (2005)
GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity
T Yoshimura et al.
CELL (2005)
Tau phosphorylation: physiological and pathological consequences
WH Stoothoff et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain
XH Li et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia
S Kelly et al.
EXPERIMENTAL NEUROLOGY (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
NGF-induced axon growth is mediated by localized inactivation of GSK-30 and functions of the microtubule plus end binding protein APC
FQ Zhou et al.
NEURON (2004)
Inactivation of glycogen synthase kinase-3β protects against kainic acid-induced neurotoxicity in vivo
S Goodenough et al.
BRAIN RESEARCH (2004)
Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium:: involvements of Bcl-2 and Bax
MBH Youdim et al.
NEUROPHARMACOLOGY (2004)
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
RS Jope
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium - Evidence for autoregulation of GSK-3
F Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of glycogen synthase kinase 3β in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones
R Owen et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
β-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system
D Zechner et al.
DEVELOPMENTAL BIOLOGY (2003)
Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in β-catenin overexpressing transgenic mice
A Chenn et al.
CEREBRAL CORTEX (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity
S Etienne-Manneville et al.
NATURE (2003)
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments
F Hernández et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice
SA Irwin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain
HB Yao et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2002)
Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice
K Spittaels et al.
NEUROSCIENCE (2002)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
CLASPs are CLIP-115 and-170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts
A Akhmanova et al.
CELL (2001)
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
WJ Ryves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
JJ Lucas et al.
EMBO JOURNAL (2001)
Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation
J Zumbrunn et al.
CURRENT BIOLOGY (2001)
Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
K Spittaels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Arrow encodes an LDL-receptor-related protein essential for Wingless signalling
M Wehrli et al.
NATURE (2000)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
分享论文
